For: | Ren JY, Wang D, Zhu LH, Liu S, Yu M, Cai H. Combining systemic inflammatory response index and albumin fibrinogen ratio to predict early serious complications and prognosis after resectable gastric cancer. World J Gastrointest Oncol 2024; 16(3): 732-749 [PMID: PMC10989372 DOI: 10.4251/wjgo.v16.i3.732] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v16/i3/732.htm |
Number | Citing Articles |
1 |
Yuxin Zhang, Zelin Li, Jiamao Zhang, Tatenda Mafa, Jingyu Zhang, Hui Zhu, Lifang Chen, Zhen Zong, Lingling Yang. Fibrinogen: A new player and target on the formation of pre-metastatic niche in tumor metastasis. Critical Reviews in Oncology/Hematology 2025; 207: 104625 doi: 10.1016/j.critrevonc.2025.104625
|
2 |
A. H. Dzhigkaev, A. M. Tynterova, I. I. Kozenkov, E. V. Khaibulin, E. V. Trofimova, K. Yu. Popadin, K. V. Gunbin, A. G. Goncharov. Clinical, functional and neuropsychological status of joint replacement patients. Genij Ortopedii 2024; 30(5): 659 doi: 10.18019/1028-4427-2024-30-5-659-669
|
3 |
Junyu Zheng, Lijun Zheng, Xiao Wang, Xuelian Mao, Qin Wang, Yining Yang, Dongping Mo. The Clinical Value of the Combined Detection of Systemic Immune-Inflammation Index (SII), Systemic Inflammation Response Index (SIRI), and Prognostic Nutritional Index (PNI) in Early Diagnosis of Gastric Cancer. Journal of Inflammation Research 2025; : 813 doi: 10.2147/JIR.S496703
|
4 |
Xiaobin Gu, Xiaodan Han, Yanli Shen, Yonggang Shi. Prognostic value of systemic inflammation response index in cancer patients treated with PD-1/PD-L1 immune checkpoint inhibitors: a meta-analysis. Annals of Medicine 2024; 56(1) doi: 10.1080/07853890.2024.2413415
|
5 |
Zhenglin Zhang, Ganlin Wang, Xiaonong Dai, Wenjian Li. Association between the systemic inflammation response index and kidney stones in US adults: a cross-sectional study based on NHANES 2007–2018. Urolithiasis 2024; 52(1) doi: 10.1007/s00240-024-01668-y
|
6 |
Huifen Shen, Fei Zuo. Prognostic role of systemic inflammation response index (SIRI) in patients with pancreatic cancer: a meta-analysis. Frontiers in Oncology 2024; 14 doi: 10.3389/fonc.2024.1465279
|